Vaccine Ontology
15687 terms(s) returned
| Term Type: | Record: 12101 to 12150 of 15687 Records | Page: 243 of 314, First Previous Next Last | Show Records Per Page |
- human papillomavirus DNA plasmids therapeutic vaccine VGX-3100
- human papillomavirus E6/E7 DNA vaccine GX-188E
- human papillomavirus -11 vaccine
- human papillomavirus 16 E7 peptide/padre 965.10 vaccine
- human papillomavirus 16/18 L1 virus-like particle/AS04 vaccine
- human papillomavirus 9-valent vaccine
- human papillomavirus tumor antigen vaccine
- human papillomavirus type 16, L1 capsid protein (residues 2-471) vaccine 0.04 MG/ML / human papillomavirus type 18, L1 capsid protein (residues 2-472) vaccine 0.04 MG/ML Injectable Suspension
- human papillomavirus type 16, L1 capsid protein (residues 2-471) vaccine 0.04 MG/ML / human papillomavirus type 18, L1 capsid protein (residues 2-472) vaccine 0.04 MG/ML Injectable Suspension [Cervarix]
- human papillomavirus type 16, L1 capsid protein (residues 2-471) vaccine 0.04 MG/ML / human papillomavirus type 18, L1 capsid protein (residues 2-472) vaccine 0.04 MG/ML Prefilled Syringe
- human papillomavirus type 16, L1 capsid protein (residues 2-471) vaccine 0.04 MG/ML / human papillomavirus type 18, L1 capsid protein (residues 2-472) vaccine 0.04 MG/ML Prefilled Syringe [Cervarix]
- human papillomavirus vaccine
- human papillomavirus vaccine V503
- human parasite role
- human protein
- human rabies vaccine from Chicken fibroblast culture
- human respiratory syncytial virus
- human senior age range at vaccination
- human serum albumin
- human serum albumin vaccine additive
- human serum cell culture residual in vaccine
- human vaccinee
- human vaccinee at age 2-17 years old
- human vaccinee population
- human vaccinee population at age 2-17 years old
- human-bovine reassortant rotavirus strain G1 vaccine / human-bovine reassortant rotavirus strain G2 vaccine / human-bovine reassortant rotavirus strain G3 vaccine / human-bovine reassortant rotavirus strain G4 vaccine / human-bovine reassortant rotavirus strain P1A[8] vaccine Oral Suspension
- human-bovine reassortant rotavirus strain G1 vaccine / human-bovine reassortant rotavirus strain G2 vaccine / human-bovine reassortant rotavirus strain G3 vaccine / human-bovine reassortant rotavirus strain G4 vaccine / human-bovine reassortant rotavirus strain P1A[8] vaccine Oral Suspension [RotaTeq]
- human-bovine reassortant rotavirus strain G1 vaccine 1100000 UNT/ML / human-bovine reassortant rotavirus strain G2 vaccine 1400000 UNT/ML / human-bovine reassortant rotavirus strain G3 vaccine 1100000 UNT/ML / human-bovine reassortant rotavirus strain G4 vaccine 1000000 UNT/ML / human-bovine reassortant rotavirus strain P1A[8] vaccine 1150000 UNT/ML Oral Suspension
- humoral immune marker
- humoral immune response
- humoral immune response to vaccine
- hyperacute - breast cancer vaccine
- hyperacute-melanoma vaccine
- hyperacute-prostate cancer vaccine
- hypersensitity to arginine
- hypersensitity to gelatin
- hypersensitivity to antibiotic
- hypersensitivity to chicken egg
- hypersensitivity to chicken product
- hypersensitivity to gentamicin
- hypersensitivity to neomycin
- hypersensitivity to polymyxin
- hypodermis
- iCP0 from Herpes simplex virus type 1 and 2
- ick-borne Encephalitis Virus C protein mutant vaccine
- icsA/virG from Shigella
- id
- identifier
- identifier
- iglB from Francisella tularensis
